Immatics NV (IMTX) is around the top of the Biotechnology industry according to InvestorsObserver. IMTX received an overall rating of 81, which means that it scores higher than 81 percent of all stocks. Immatics NV also achieved a score of 98 in the Biotechnology industry, putting it above 98 percent of Biotechnology stocks. Biotechnology is ranked 75 out of the 148 industries.
IMTX has an Overall Score of 81. Find out what this means to you and get the rest of the rankings on IMTX!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.
What's Happening With Immatics NV Stock Today?
Immatics NV (IMTX) stock has fallen -1.58% while the S&P 500 has gained 0.23% as of 12:43 PM on Monday, Sep 25. IMTX has fallen -$0.19 from the previous closing price of $11.71 on volume of 156,231 shares. Over the past year the S&P 500 has gained 18.47% while IMTX has gained 25.19%. IMTX lost -$1.14 per share the over the last 12 months.
Click Here to get the full Stock Report for Immatics NV stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
